MedPath

Found 556472 clinical trials

Sort by:

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Not Applicable

Not yet recruiting

Conditions: Neoplasms, Colorectal

Interventions: Drug: GSK5460025

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 47

Registration Number: NCT07213609

Alpha tACS for Disorders of Consciousness : a Single Case Experimental Design

Not Applicable

Not yet recruiting

Conditions: Disorder of Consciousness

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 5

Registration Number: NCT07213869

Locations: 🇫🇷
Post-Intensive Care Neurorehabilitation Unit (Service de Reeducation Post-Reanimation) in Pierre Wertheimer Neurologic Hospital, Bron, France

External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

Not Applicable

Recruiting

Conditions: Attention Deficit Disorder With Hyperactivity (ADHD)
Autism Spectrum Disorder (ASD)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT07214545

Locations: 🇺🇸
UCSF Nancy Friend Pritzker Psychiatry Building, San Francisco, California, United States

Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse

Not Applicable

Not yet recruiting

Conditions: Opioid Use
Surgical Recovery
Vaginal Hysterectomy
Prolapse Pelvic
Postoperative Pain

Interventions: Drug: Bupivacaine-epinephrine
Drug: Normal saline

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 56

Registration Number: NCT07213635

Locations: 🇺🇸
University of North Carolina Urogynecology and Reconstructive Pelvic Surgery at REX, Raleigh, North Carolina, United States

Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families

Not Applicable

Not yet recruiting

Conditions: Short Interpregnancy Intervals
Maternal Health Disparities

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Tennessee Graduate School of Medicine

Target Recruit Count: 60

Registration Number: NCT07214012

Locations: 🇺🇸
University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, United States

Follicular Fluid microRNAs in Ovarian Aging and Reproduction

Recruiting

Conditions: Ovarian Aging
In Vitro Fertilisation (IVF) Treatment
InVitro Fertilization
In Vitro Fertilization Outcome

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Central Florida

Target Recruit Count: 100

Registration Number: NCT07214246

Locations: 🇺🇸
University of Central Florida, Orlando, Florida, United States

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Not Applicable

Not yet recruiting

Conditions: Allogeneic Stem Cell Transplant Recipient

Interventions: Drug: Fludarabine
Radiation: Intermediate-dose Total Body Irradiation (TBI)
Drug: Post-transplant Cyclophosphamide (PTCy)
Drug: Tacrolimus
Drug: Mycophenolate mofetil (MMF)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 209

Registration Number: NCT07214688

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
John Theurer Cancer Center at Jersey Shore University Medical Center, Neptune City, New Jersey, United States

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Not Applicable

Not yet recruiting

Conditions: Prostate Cancer (CRPC)
Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Interventions: Drug: AB001

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: ARTBIO Inc.

Target Recruit Count: 80

Registration Number: NCT07214961

Locations: 🇺🇸
BAMF Health, Grand Rapids, Michigan, United States
🇺🇸
Washington University, St Louis, Missouri, United States
🇺🇸
XCancer, 17607 Gold Plaza, Omaha, Nebraska, United States

and more 1 locations

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Not Applicable

Not yet recruiting

Conditions: Bipolar I Disorder
Bipolar II Disorder
Schizo Affective Disorder
Obesity
Weight Loss
GLP - 1

Interventions: Behavioral: Group Therapy Program
Drug: semaglutide
Drug: naltrexone and bupropion (combination)
Drug: Phentermine-Topiramate

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT07213466

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Intervention for Alcohol Use Disorder Recovery After Liver Transplantation

Not Applicable

Not yet recruiting

Conditions: Liver Transplant Recipient
Alcohol Use Disorders (AUD)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Leigh Anne Dageforde

Target Recruit Count: 40

Registration Number: NCT07214259

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

AI-Powered Research

Premium Access

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Alpha tACS for Disorders of Consciousness : a Single Case Experimental Design

External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse

Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families

Follicular Fluid microRNAs in Ovarian Aging and Reproduction

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Intervention for Alcohol Use Disorder Recovery After Liver Transplantation

Product

Company

Legal